Literature DB >> 24418552

HTLV-1 infects human mesenchymal stromal cell in vitro and modifies their phenotypic characteristics.

Evandra Strazza Rodrigues1, Mayra Dorigan de Macedo1, Mariana Tomazini Pinto1, Maristela Delgado Orellana2, Maurício Cristiano Rocha Junior1, Danielle Aparecida Rosa de Magalhães3, Yuetsu Tanaka4, Osvaldo Massaiti Takayanagui5, Dimas Tadeu Covas2, Simone Kashima6.   

Abstract

The typical characteristics of mesenchymal stem cells (MSCs) can be affected by inflammatory microenvironment; however, the exact contribution of HTLV-1 to MSC dysfunction remains to be elucidated. In this study, we demonstrated that MSC cell surface molecules VCAM-1 and ICAM-1 are upregulated by contact with HTLV-1, and HLA-DR was most highly expressed in MSCs co-cultured with MT2 cells. The expression levels of VCAM-1 and HLA-DR were increased in MSCs cultured in the presence of PBMCs isolated from HTLV-1-infected symptomatic individuals compared with those cultured with cells from asymptomatic infected individuals or healthy subjects. HTLV-1 does not impair the MSC differentiation process into osteocytes and adipocytes. In addition, MSCs were efficiently infected with HTLV-1 in vitro through direct contact with HTLV-1-infected cells; however, cell-free virus particles were not capable of causing infection. In summary, HTLV-1 can alter MSC function, and this mechanism may contribute to the pathogenesis of this viral infection.
© 2013 Published by Elsevier Inc.

Entities:  

Keywords:  ACTB; ATLL; BM; CD105; CD106; CD13; CD271; CD45; CD73; CD90; CMV; ENG, endoglin; GAPDH; GLUT1; HAC; HAM/TSP; HHV; HLA-ABC; HLA-class I; HSPG2; HTLV asymptomatic carriers; HTLV-1; HTLV-associated myelopathy/tropical spastic paraparesis; Human mesenchymal stromal cells; MSC; MSC differentiation; MSC virus infection; NGFR, nerve growth factor receptor; NRP1; NT5E, 5-nucleotidase, ecto; PBMC; PPARγ; RUNX-2; THY1, Thy-1 cell surface antigen; URE; VCAM1, vascular cell adhesion molecule 1; adult T-cell leukemia/lymphoma; aminopeptidase-N; beta-actin; bone marrow; cytomegalovirus; expression relative units; glyceraldehyde-3-phosphate dehydrogenase; heparan sulfate proteoglycan 2; human herpesvirus, HHV8; human major histocompatibility complex (MHC) class I, HLA-A, B, C; human major histocompatibility complex, class I; leukocyte common; mesenchymal stromal cells; neuropilins 1; peripheral blood mononuclear cells; peroxisome proliferator-activated receptors gamma; runt-related transcription factor-2; solute carrier family 2 (facilitated glucose transporter), member 1

Mesh:

Substances:

Year:  2013        PMID: 24418552     DOI: 10.1016/j.virol.2013.11.022

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  2 in total

1.  HTLV-1 viral oncogene HBZ drives bone destruction in adult T cell leukemia.

Authors:  Jingyu Xiang; Daniel A Rauch; Devra D Huey; Amanda R Panfil; Xiaogang Cheng; Alison K Esser; Xinming Su; John C Harding; Yalin Xu; Gregory C Fox; Francesca Fontana; Takayuki Kobayashi; Junyi Su; Hemalatha Sundaramoorthi; Wing Hing Wong; Yizhen Jia; Thomas J Rosol; Deborah J Veis; Patrick L Green; Stefan Niewiesk; Lee Ratner; Katherine N Weilbaecher
Journal:  JCI Insight       Date:  2019-10-03

2.  Human T-cell leukemia virus type 1 infects multiple lineage hematopoietic cells in vivo.

Authors:  Rie Furuta; Jun-Ichirou Yasunaga; Michi Miura; Kenji Sugata; Akatsuki Saito; Hirofumi Akari; Takaharu Ueno; Norihiro Takenouchi; Jun-Ichi Fujisawa; Ki-Ryang Koh; Yusuke Higuchi; Mohamed Mahgoub; Masakazu Shimizu; Fumihiko Matsuda; Anat Melamed; Charles R Bangham; Masao Matsuoka
Journal:  PLoS Pathog       Date:  2017-11-29       Impact factor: 6.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.